Dr Reddy’s Laboratories Ltd has launched Clofarabine Injection, in the United States market, a remedy which is identical generic version of Clolar (clofarabine) Injection.

The generic version of the injection is available in single-dose, 20 ml flint vials containing 20 mg of clofarabine in 20 ml of solution (1mg/mL).

Further, Clofarabine Injection is used to treat acute Lymphoblastic Leukemia, a cancer of white blood cells.

Read EquityPandit’s Technical Analysis of Dr Reddy